Cynata Therapeutics Ltd Price Chart
Cynata Therapeutics Ltd 51S.BE Financial and Trading Overview
| Cynata Therapeutics Ltd stock price | 0.11 EUR |
| Previous Close | 0.09 EUR |
| Open | 0.09 EUR |
| Bid | 0.21 EUR x 0 |
| Ask | 0.34 EUR x 0 |
| Day's Range | 0.09 - 0.09 EUR |
| 52 Week Range | 0.08 - 0.3 EUR |
| Volume | 103 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
51S.BE Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Cynata Therapeutics Ltd Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.3 EUR |
| 52 Week Low | 0.08 EUR |
| 50-Day Moving Average | 0.11 EUR |
| 200-Day Moving Average | 0.18 EUR |
51S.BE Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Cynata Therapeutics Ltd Stock
What is a current 51S.BE stock price?
Cynata Therapeutics Ltd 51S.BE stock price today per share is 0.11 EUR.
How to purchase Cynata Therapeutics Ltd stock?
You can buy 51S.BE shares on the Berlin exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cynata Therapeutics Ltd?
The stock symbol or ticker of Cynata Therapeutics Ltd is 51S.BE.
How many shares does Cynata Therapeutics Ltd have in circulation?
The max supply of Cynata Therapeutics Ltd shares is 0.
What is Cynata Therapeutics Ltd Price to Earnings Ratio (PE Ratio)?
Cynata Therapeutics Ltd PE Ratio is now.
What was Cynata Therapeutics Ltd earnings per share over the trailing 12 months (TTM)?
Cynata Therapeutics Ltd EPS is 0 EUR over the trailing 12 months.